Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Vogel

Showing results (91-100 of 185) with videos related to

Pageof 19
Sort By:
Atherosclerosis|October 10, 2025
Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary interventionAngelo Oliva, Mark Shneyderman, Mauro Gitto, et al.
Circulation|October 23, 2023
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized TrialsUsman Baber, Yangsoo Jang, Angelo Oliva, et al.
European Heart Journal. Acute Cardiovascular Care|December 26, 2025
Guided De-escalation of Antiplatelet Treatment in Patients at High Atherothrombotic Risk Presenting With Acute Coronary Syndrome: A Post-Hoc Analysis of the TROPICAL-ACS trialSerdar Farhan, Ralph Hein, Dietmar Trenk, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 24, 2023
Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registryAlessandro Spirito, Davide Cao, Samantha Sartori, et al.
The American Journal of Cardiology|October 24, 2024
Clinical Outcomes After Percutaneous Coronary Intervention for Left Main Coronary Artery Disease in Patients of Diverse Race/EthnicityPier Pasquale Leone, Samantha Sartori, Jonathan Murphy, et al.
JAMA Cardiology|August 27, 2020
Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical TrialSerdar Farhan, Birgit Vogel, Gilles Montalescot, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 13, 2020
Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCIJaya Chandrasekhar, George Dangas, Usman Baber, et al.
The American Journal of Cardiology|April 24, 2025
Inflammation and Contrast-Associated Acute Kidney Injury in Patients Undergoing Percutaneous Coronary InterventionMark Shneyderman, Johny Nicolas, Samantha Sartori, et al.
The American Journal of Cardiology|February 26, 2017
Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary InterventionSerdar Farhan, Usman Baber, Birgit Vogel, et al.
European Journal of Preventive Cardiology|September 5, 2019
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiativeSerdar Farhan, Usman Baber, Birgit Vogel, et al.
Pageof 19

Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
Atherosclerosis|October 10, 2025
Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary interventionAngelo Oliva, Mark Shneyderman, Mauro Gitto, et al.
Circulation|October 23, 2023
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized TrialsUsman Baber, Yangsoo Jang, Angelo Oliva, et al.
European Heart Journal. Acute Cardiovascular Care|December 26, 2025
Guided De-escalation of Antiplatelet Treatment in Patients at High Atherothrombotic Risk Presenting With Acute Coronary Syndrome: A Post-Hoc Analysis of the TROPICAL-ACS trialSerdar Farhan, Ralph Hein, Dietmar Trenk, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 24, 2023
Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registryAlessandro Spirito, Davide Cao, Samantha Sartori, et al.
The American Journal of Cardiology|October 24, 2024
Clinical Outcomes After Percutaneous Coronary Intervention for Left Main Coronary Artery Disease in Patients of Diverse Race/EthnicityPier Pasquale Leone, Samantha Sartori, Jonathan Murphy, et al.
JAMA Cardiology|August 27, 2020
Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical TrialSerdar Farhan, Birgit Vogel, Gilles Montalescot, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 13, 2020
Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCIJaya Chandrasekhar, George Dangas, Usman Baber, et al.
The American Journal of Cardiology|April 24, 2025
Inflammation and Contrast-Associated Acute Kidney Injury in Patients Undergoing Percutaneous Coronary InterventionMark Shneyderman, Johny Nicolas, Samantha Sartori, et al.
The American Journal of Cardiology|February 26, 2017
Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary InterventionSerdar Farhan, Usman Baber, Birgit Vogel, et al.
European Journal of Preventive Cardiology|September 5, 2019
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiativeSerdar Farhan, Usman Baber, Birgit Vogel, et al.
Pageof 19